Global Health Events
In an effort to fulfill our mission to advance global cancer research, the Center for Global Health sponsors and participates in a number of global health events for both national and international audiences. Although events vary by region and topic, they all focus on the open exchange of scientific knowledge.
Upcoming Events
International Cancer Screening Conference 2019
June 3-5, 2019
Location: Rotterdam, Netherlands
NCI-CGH and Erasmus MC Department of Public Health are organizing the 2019 International Cancer Screening Network (ICSN) Conference which will take place in Rotterdam, Netherlands, on June 3-5, 2019. The theme of the conference will be Screening in Balance, emphasizing the importance of continuously weighing the benefits and harms of cancer screening programs. ICSN 2019 will focus on collaborative research that fosters efficient and effective approaches to cancer control worldwide through organized approaches to population-based cancer screening. For more information about the conference, please visit https://icsn2019.com/.
Past Events
7th Annual Symposium on Global Cancer Research: Translation & Implementation for Impact in Global Cancer Research
March 7, 2019
Location: Chicago, Illinois
The 7th Annual Symposium on Global Cancer Research is a collaboration between the National Cancer Institute, Consortium of Universities for Global Health, University of Chicago Comprehensive Cancer Center, University of Illinois Cancer Center, Northwestern Medicine Robert H. Lurie Comprehensive Cancer Center, Indiana University Melvin and Bren Simon Cancer Center, American Society for Clinical Pathology, and American Society of Clinical Oncology. This meeting will address cancer research and oncology in low- and middle-income countries and focus on the need for cancer care, prevention, research, and innovation to become a global priority. Download the 7th Annual Symposium on Global Cancer Research agenda.
For more information and to register, visit: https://7th-annual-sypmosium-on-global-cancer-research.eventbrite.com or view our conference flyer.
Breast Health Global Initiative Summit 2018
October 15-17, 2018
Location: Seattle, Washington
CGH will participate at the Breast Health Global Initiative Global Summit 2018 in October. This year's focus is on International Breast Health and Cancer Control: Improving Breast Health Care through Resource Stratified Phased Implementation, and provides a unique opportunity for the international community to examine the current state of scientific understanding regarding successful models of breast cancer diagnosis, care delivery, and resource utilization, and to analyze issues affecting barriers in access to care.
European Society for Medical Oncology 2018 Congress
October 19-23, 2018
Location: Munich, Germany
Dr. Lisa Stevens, CGH’s Deputy Director, and Dr. Sophia Michaelson, CGH’s Head of Eurasia Programs, discuss with representatives from Eurasian countries the experiences and lessons learned in the development and implementation of National Cancer Control Plans at the European Society for Medical Oncology 2018 Congress session on Oct. 20th: The way to assure sustainable, accessible and affordable cancer care within National Cancer Control Plans (NCCP).
2018 World Cancer Congress
October 1-4, 2018
Location: Kuala Lumpur, Malaysia
Representatives from the National Cancer Institute will be participating at the 2018 World Cancer Congress in a variety of presentations and ePoster sessions. This year, the World Cancer Congress aims to strengthen the participants' action and impact on national, regional, and international scales through a multidisciplinary program that features the latest successful interventions in cancer prevention, diagnosis, treatment and care. Click here to view a schedule of all NCI activities.
Asia Pacific Conference on Tobacco or Health
September 13-15, 2018
Location: Nusa Dua, Indonesia
Dr. Mark Parascandola will represent CGH at the 12th Asia Pacific Conference on Tobacco or Health (APACT) in Nusa Dua, Indonesia. CGH has organized a special symposium session, “Strategies for research and developing policy interventions on betel quid and areca nut to prevent oral cancers.” Dr. Parascandola will be presenting research on betel quid and areca nut (BQ/AN) at the special symposium session as well as in a rapid-fire session to raise awareness of the burden of disease caused by BQ/AN use in the region.
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings Webinar
July 24, 2018
Location: Webinar
CGH and Small Business Innovation Research (SBIR) hosted a joint informational webinar to discuss two new funding opportunities for Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (Clinical Trial Optional) on Tuesday, July 24th. These funding opportunities encourage SBIR and Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries and low-resource settings in the United States. R41/42 PAR-18-802; R43/R44 PAR-18-801. Visit CGH's Funding for Global Research and Training webpage to download webinar presentations.
Affordable Cancer Technologies Program Principal Investigator Meeting
Cancer Detection, Diagnosis, and Treatment Technologies for Global Health
May 10-11, 2018
Location: Bethesda, Maryland
The National Cancer Institute, in collaboration with the National Institute of Biomedical Imaging and Bioengineering, supports the translation of resource-appropriate technologies for global health through the Affordable Cancer Technologies Program. The NCI Center for Global Health hosts the Affordable Cancer Technologies Program Principal Investigator Meeting: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health to highlight the impact of research on early detection, diagnosis, and non-invasive or minimally invasive treatment of cancer. Learn more about the Affordable Cancer Technologies Program.
Eurasian Cancer Screening Conference 2018
May 17-18, 2018
Location: Minsk, Belarus
CGH is partnering with N.N. Alexandrov National Cancer Center of Belarus and WHO Collaborating Center for Cancer Screening and Early Detection to organize a cancer screening conference focused on the needs and priorities of the Commonwealth of Independent States (CIS), including countries in Central and Eastern Europe, Baltics, Caucasus and Central Asia, in response to growing interest and participation in cancer screening research and implementation in the region. The Eurasian Cancer Screening Conference 2018 (ECSC 2018) addresses themes in cancer screening relevant to the CIS, in the areas of cervical, breast, colorectal and prostate cancer. ECSC 2018 is an opportunity for cancer screening researchers, program implementers, and decision makers to exchange best practices and discuss the evidence available for the implementation and evaluation of effective cancer screening strategies that could have a positive impact on the cancer burden in the region. In addition, it will offer an opportunity for U.S.-based cancer screening researchers to gain knowledge on strategies and success stories of CIS cancer screening programs, especially considering cancer types for which screening programs are not in place in the USA and where the evidence is still developing, such as prostate cancer; researchers will also discuss the feasibility of cancer screening research projects that may have applications to U.S. settings and populations.
2018 International Cancer Research Partnership Annual Meeting
April 11, 2018
Location: Bethesda, Maryland
Organizations funding cancer research around the world attend the International Cancer Research Partnership’s 2018 annual meeting on Wednesday April 11th, 2018 at the NCI/NIH Campus, Bethesda, MD. The meeting is hosted by the U.S. National Cancer Institute and the U.S. Congressionally-Directed Medical Research Programs. The theme is “Advancing cancer research through global partnership” and addresses trends in cancer research over the last ten years, gaps and opportunities moving forward, and innovative co-funding strategies to promote cross-sector and international collaboration.